Lonza Group Ag EBITDA 2012-2024 | LZAGY

Lonza Group Ag annual and quarterly EBITDA history from 2012 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Lonza Group Ag EBITDA for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Lonza Group Ag EBITDA for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Lonza Group Ag 2023 annual EBITDA was $1.229B, a 41.29% decline from 2022.
  • Lonza Group Ag 2022 annual EBITDA was $2.093B, a 49.54% increase from 2021.
  • Lonza Group Ag 2021 annual EBITDA was $1.399B, a 4.93% decline from 2020.
Lonza Group Ag Annual EBITDA
(Millions of US $)
2023 $1,229
2022 $2,093
2021 $1,399
2020 $1,472
2019 $1,526
2017 $1,152
2016 $805
2015 $445
2014 $790
2013 $607
2012 $682
2011 $608
Lonza Group Ag Quarterly EBITDA
(Millions of US $)
2024-12-31
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2015-06-30
2014-12-31
2014-06-30
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $51.237B $7.468B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $152.324B 38.13
Stryker (SYK) United States $149.641B 31.29
EssilorLuxottica (ESLOY) France $137.721B 0.00
Medtronic (MDT) Ireland $114.146B 16.18
Haleon (HLN) United Kingdom $45.147B 25.77
ResMed (RMD) United States $37.534B 28.19
GE HealthCare Technologies (GEHC) United States $34.575B 16.42
Agilent Technologies (A) United States $34.457B 22.46
Terumo (TRUMY) Japan $25.051B 32.54
Koninklijke Philips (PHG) Netherlands $23.235B 16.30
Insulet (PODD) United States $20.934B 82.17
Zimmer Biomet Holdings (ZBH) United States $18.835B 12.10
Baxter (BAX) United States $15.298B 11.42
Smith & Nephew SNATS (SNN) United Kingdom $13.441B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.887B 23.97
Lantheus Holdings (LNTH) United States $5.776B 14.57
Prestige Consumer Healthcare (PBH) United States $3.897B 17.41
Perrigo (PRGO) Ireland $3.742B 9.48
Haemonetics (HAE) United States $3.724B 16.96
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.454B 28.70
ICU Medical (ICUI) United States $3.341B 24.63
QuidelOrtho (QDEL) United States $2.135B 14.68
LeMaitre Vascular (LMAT) United States $1.910B 42.70
AtriCure (ATRC) United States $1.580B 0.00
Acuren (TIC) United States $1.397B 0.00
Phibro Animal Health (PAHC) United States $1.272B 16.26
Green Thumb Industries (GTBIF) United States $1.249B 28.09
AdaptHealth (AHCO) United States $1.247B 12.66
Neogen (NEOG) United States $1.194B 15.28
BioLife Solutions (BLFS) United States $1.068B 0.00
InMode (INMD) Israel $0.963B 9.70
Kestra Medical Technologies (KMTS) United States $0.791B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.703B 0.00
Tilray Brands (TLRY) Canada $0.679B 0.00
Curaleaf Holdings (CURLF) Canada $0.670B 0.00
Owens & Minor (OMI) United States $0.667B 5.53
Evolus (EOLS) United States $0.623B 0.00
CeriBell (CBLL) United States $0.596B 0.00
Capricor Therapeutics (CAPR) United States $0.522B 0.00
Valneva SE (VALN) France $0.502B 0.00
Surmodics (SRDX) United States $0.441B 0.00
SNDL (SNDL) Canada $0.373B 0.00
VAREX IMAGING (VREX) United States $0.347B 12.77
Sanuwave Health (SNWV) United States $0.308B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.295B 0.00
Cresco Labs (CRLBF) United States $0.291B 0.00
Cerus (CERS) United States $0.285B 0.00
Viemed Healthcare (VMD) United States $0.276B 23.27
Sanara MedTech (SMTI) United States $0.269B 0.00
ZimVie (ZIMV) United States $0.264B 12.01
Brainsway (BWAY) Israel $0.246B 65.00
Canopy Growth (CGC) Canada $0.232B 0.00
OraSure Technologies (OSUR) United States $0.227B 0.00
Biote (BTMD) United States $0.225B 6.34
Verano Holdings (VRNOF) United States $0.210B 0.00
Omeros (OMER) United States $0.198B 0.00
Organigram Global (OGI) Canada $0.193B 0.00
High Tide (HITI) Canada $0.190B 0.00
TriSalus Life Sciences (TLSI) United States $0.190B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.15
Vireo Growth (VREOF) United States $0.150B 0.00
Exagen (XGN) United States $0.145B 0.00
FitLife Brands (FTLF) United States $0.126B 15.53
TerrAscend (TSNDF) Canada $0.104B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Fonar (FONR) United States $0.096B 12.37
Jin Medical (ZJYL) China $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Apyx Medical (APYX) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.082B 0.00
Veru (VERU) United States $0.081B 0.00
Jushi Holdings (JUSHF) United States $0.072B 0.00
Zynex (ZYXI) United States $0.072B 0.00
InterCure (INCR) Israel $0.072B 0.00
Agape ATP (ATPC) $0.071B 0.00
Cytosorbents (CTSO) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Rockwell Medical (RMTI) United States $0.041B 0.00
Nephros (NEPH) United States $0.040B 53.29
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.037B 12.82
Safety Shot (SHOT) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.016B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00